Asymptomatic Hyperuricemia as an Independent Risk Factor for Myocardial Infarction in Adult Population: A Four-Year Follow-Up Study

被引:5
作者
Talpur, Abdul Subhan [1 ]
Fattah, Abdul [2 ]
Hewadmal, Hewad [3 ]
Hafizyar, Farukhzad [4 ]
Farooq, Jawad [1 ]
Shaik, Tanveer Ahamad [5 ,6 ]
Qadar, Laila Tul [7 ]
Zaidi, Syed Muhammad Hussain [8 ]
Pirzada, Sarmad [9 ]
Bahar, Abdul Rasheed [4 ]
机构
[1] Liaquat Univ Med & Hlth Sci, Med, Jamshoro, Pakistan
[2] Indus Med Coll, Internal Med, Tando Muhammad Khan, Pakistan
[3] Sheikh Zayed Med Coll Hosp, Cardiol, Rahim Yar Khan, Pakistan
[4] Liaquatian Res Council, Internal Med, Hyderabad, Andhra Pradesh, India
[5] Univ Louisville, Cardiovasc Med, Sch Med, Louisville, KY USA
[6] Liaquatian Res Council, Cardiovasc Med, Hyderabad, Andhra Pradesh, India
[7] Dow Univ Hlth Sci, Civil Hosp Karachi, Internal Med, Karachi, Pakistan
[8] Dow Univ Hlth Sci, Internal Med, Karachi, Pakistan
[9] Internal Med, Trinity Hlth Livonia, Livonia, MI USA
关键词
acute myocardial infarction in pakistan; cardiac risk factors and prevention; fatal myocardial infarction; non-fatal myocardial infarction; elevated uric acid levels; SERUM URIC-ACID; CARDIOVASCULAR-DISEASE; INCIDENT HYPERTENSION; ASSOCIATION; ATHEROSCLEROSIS; MORTALITY; EVENTS;
D O I
10.7759/cureus.34614
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction A condition in which uric acid levels are elevated but there are no accompanying symptoms is known as asymptomatic hyperuricemia. As a result of the disparity in opinions and findings between the studies, the guidelines regarding whether or not asymptomatic hyperuricemia should be treated are unclear. Material and methods Between the months of January 2017 and June 2022, this research was carried out in the community in collaboration with the internal medicine unit and the public health unit of Liaquat University of Medical and Health Sciences. After obtaining informed consent from each participant, the researchers enrolled 1,500 patients in the study who had uric acid levels that were greater than 7.0 mg/dL. These patients ranged in age from 40 to 70 years old and were of either gender. As a control group, 1,500 patients were recruited who did not have abnormally high levels of uric acid. Patients were monitored for a total of 48 months or until the occurrence of a major cardiovascular event (MACCE) or death from all causes, whichever occurred first. Death, cardiovascular mortality, non-fatal myocardial infarction, and non-fatal stroke were the four categories that made up the primary outcome, also known as MACCEs. Results In the hyperuricemic group, the incidence of myocardial infarction that did not result in death was significantly higher than in the non-hyperuricemic group (1.6% vs. 0.7%; p-value, 0.04). However, the result was not significant for deaths from all causes, deaths from cardiovascular disease, or strokes that did not result in death. Conclusion Asymptomatic hyperuricemia is a potential threat to one's health that can lead to cardiovascular diseases and may go undiagnosed in some cases. It is important to remember that hyperuricemia can lead to delirious complications, so efforts should be made to perform routine monitoring and management of the condition.
引用
收藏
页数:5
相关论文
共 23 条
  • [1] Serum uric acid and cardiovascular disease: Recent developments, and where do they leave us?
    Baker, JF
    Krishnan, E
    Chen, L
    Schumacher, HR
    [J]. AMERICAN JOURNAL OF MEDICINE, 2005, 118 (08) : 816 - 826
  • [2] Uric acid is a risk factor for myocardial infarction and stroke - The Rotterdam Study
    Bos, Michiel J.
    Koudstaal, Peter J.
    Hofman, Albert
    Witteman, Jacqueline C. M.
    Breteler, Monique M. B.
    [J]. STROKE, 2006, 37 (06) : 1503 - 1507
  • [3] Management of hyperuricemia in asymptomatic patients: A critical appraisal
    Brucato, Antonio
    Cianci, Francesco
    Carnovale, Carla
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2020, 74 : 8 - 17
  • [4] Burgos J, 1991, Rev Chil Pediatr, V62, P48
  • [5] MYOCARDIAL MALONDIALDEHYDE AND URIC-ACID RELEASE AFTER SHORT-LASTING CORONARY OCCLUSIONS DURING CORONARY ANGIOPLASTY - POTENTIAL MECHANISMS FOR FREE-RADICAL GENERATION
    DESCHEERDER, IK
    VANDEKRAAY, AMM
    LAMERS, JMJ
    KOSTER, JF
    DEJONG, JW
    SERRUYS, PW
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1991, 68 (04) : 392 - 395
  • [6] Relationship of lipid oxidation with subclinical atherosclerosis and 10-year coronary events in general population
    Gomez, Miquel
    Vila, Joan
    Elosua, Roberto
    Molina, Lluis
    Bruguera, Jordi
    Sala, Joan
    Masia, Rafel
    Isabel Covas, Maria
    Marrugat, Jaume
    Fito, Montserrat
    [J]. ATHEROSCLEROSIS, 2014, 232 (01) : 134 - 140
  • [7] Xanthine Oxidase Inhibition For The Treatment Of Cardiovascular Disease: A Systematic Review and Meta-Analysis
    Higgins, Peter
    Dawson, Jesse
    Lees, Kennedy R.
    McArthur, Kate
    Quinn, Terrence J.
    Walters, Matthew R.
    [J]. CARDIOVASCULAR THERAPEUTICS, 2012, 30 (04) : 217 - 226
  • [8] The impact of serum uric acid on cardiovascular outcomes in the LIFE study
    Hoieggen, A
    Alderman, MH
    Kjeldsen, SE
    Julius, S
    Devereux, RB
    de Faire, U
    Fyhrquist, F
    Ibsen, H
    Kristianson, K
    Lederballe-Pedersen, O
    Lindholm, LH
    Nieminen, MS
    Omvik, P
    Oparil, S
    Wedel, H
    Chen, C
    Dahlöf, B
    [J]. KIDNEY INTERNATIONAL, 2004, 65 (03) : 1041 - 1049
  • [9] Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417 734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)
    Holme, I.
    Aastveit, A. H.
    Hammar, N.
    Jungner, I.
    Walldius, G.
    [J]. JOURNAL OF INTERNAL MEDICINE, 2009, 266 (06) : 558 - 570
  • [10] Correlates of uric acid and its association with asymptomatic carotid atherosclerosis: The ARIC Study
    Iribarren, C
    Folsom, AR
    Eckfeldt, JH
    McGovern, PG
    Nieto, FJ
    [J]. ANNALS OF EPIDEMIOLOGY, 1996, 6 (04) : 331 - 340